Pages that link to "Q45710445"

The following pages link to Peroxisome proliferators reduce spatial memory impairment, synaptic failure, and neurodegeneration in brains of a double transgenic mice model of Alzheimer's disease (Q45710445):

Displaying 21 items.

• Peroxisomal Atg37 binds Atg30 or palmitoyl-CoA to regulate phagophore formation during pexophagy (Q24337501) (← links)
• Is L-methionine a trigger factor for Alzheimer's-like neurodegeneration?: Changes in Aβ oligomers, tau phosphorylation, synaptic proteins, Wnt signaling and behavioral impairment in wild-type mice (Q27301311) (← links)
• Peroxisomes and Kidney Injury (Q28595714) (← links)
• Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice (Q30645309) (← links)
• Amyloid-beta neuroprotection mediated by a targeted antioxidant. (Q33612650) (← links)
• Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs (Q33959032) (← links)
• Nuclear receptors in neurodegenerative diseases. (Q34580020) (← links)
• Peroxisome proliferator-activated receptor (PPAR) γ and PPARα agonists modulate mitochondrial fusion-fission dynamics: relevance to reactive oxygen species (ROS)-related neurodegenerative disorders? (Q34723198) (← links)
• Wnt signaling: role in Alzheimer disease and schizophrenia (Q38060562) (← links)
• Peroxisome proliferator-activated receptors and Alzheimer's disease: hitting the blood-brain barrier (Q38089668) (← links)
• Signaling pathway cross talk in Alzheimer's disease (Q38200151) (← links)
• PPAR-α agonist regulates amyloid-β generation via inhibiting BACE-1 activity in human neuroblastoma SH-SY5Y cells transfected with APPswe gene (Q38862023) (← links)
• Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes (Q38926789) (← links)
• Therapeutic potential of nuclear receptor agonists in Alzheimer's disease (Q39164346) (← links)
• Early Minocycline and Late FK506 Treatment Improves Survival and Alleviates Neuroinflammation, Neurodegeneration, and Behavioral Deficits in Prion-Infected Hamsters (Q40373414) (← links)
• Dynamic SAP102 expression in the hippocampal subregions of rats and APP/PS1 mice of various ages. (Q51759819) (← links)
• Shengmai Formula Ameliorates Pathological Characteristics in AD C. elegans. (Q53373650) (← links)
• The peroxisome: an update on mysteries 2.0 (Q57921401) (← links)
• Combinatory FK506 and Minocycline Treatment Alleviates Prion-Induced Neurodegenerative Events via Caspase-Mediated MAPK-NRF2 Pathway (Q64057223) (← links)
• The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer's Disease and Other Neurodegenerative Disorders (Q90320828) (← links)
• Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model (Q92532068) (← links)